Summary

A migraine is an episodic and unpredictable headache disorder that presents with disabling attack. Migraine is one of the most frequent disabling neurological conditions with a major impact on the patient’s quality of life. Migraine has been described as a chronic disorder that characterized with attacks. Attacks are characterized by moderate–severe, often unilateral, pulsating headache attacks, typically lasting 4 to 72 hours.

Market Analysis and Insights: Global Acute Migraine Drugs Market
Due to the COVID-19 pandemic, the global Acute Migraine Drugs market size is estimated to be worth US$ 2104.4 million in 2021 and is forecast to a readjusted size of US$ 2104.4 million by 2028 with a CAGR of 7.3% during the review period. Fully considering the economic change by this health crisis, by Type accounting for % of the Acute Migraine Drugs global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Type segment is altered to an % CAGR throughout this forecast period.
The top 3 manufacturers held about 29.5% of the market share in 2019, while top 5 hold 41.93%.

Global Acute Migraine Drugs Scope and Market Size
The global Acute Migraine Drugs market is segmented by company, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Acute Migraine Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

Segment by Type
Triptans
NSAIDs
Others

Segment by Application
Hospital Pharmacies
Drug Stores

By Region
United States
Europe
China
Japan
Southeast Asia
India
Other Regions

By Company
GSK
Teva
Pfizer
Novartis
Sun Pharma
Grunenthal
Endo Pharmaceuticals
Merck
J & J

ページTOPに戻る

Table of Contents

1 Acute Migraine Drugs Market Overview
1.1 Acute Migraine Drugs Product Scope
1.2 Acute Migraine Drugs Segment by Type
1.2.1 Global Acute Migraine Drugs Sales by Type (2017 & 2021 & 2028)
1.2.2 Triptans
1.2.3 NSAIDs
1.2.4 Others
1.3 Acute Migraine Drugs Segment by Application
1.3.1 Global Acute Migraine Drugs Sales Comparison by Application (2017 & 2021 & 2028)
1.3.2 Hospital Pharmacies
1.3.3 Drug Stores
1.4 Acute Migraine Drugs Market Estimates and Forecasts (2017-2028)
1.4.1 Global Acute Migraine Drugs Market Size in Value Growth Rate (2017-2028)
1.4.2 Global Acute Migraine Drugs Market Size in Volume Growth Rate (2017-2028)
1.4.3 Global Acute Migraine Drugs Price Trends (2017-2028)
2 Acute Migraine Drugs Estimates and Forecasts by Region
2.1 Global Acute Migraine Drugs Market Size by Region: 2017 VS 2021 VS 2028
2.2 Global Acute Migraine Drugs Retrospective Market Scenario by Region (2017-2022)
2.2.1 Global Acute Migraine Drugs Sales Market Share by Region (2017-2022)
2.2.2 Global Acute Migraine Drugs Revenue Market Share by Region (2017-2022)
2.3 Global Acute Migraine Drugs Market Estimates and Forecasts by Region (2023-2028)
2.3.1 Global Acute Migraine Drugs Sales Estimates and Forecasts by Region (2023-2028)
2.3.2 Global Acute Migraine Drugs Revenue Forecast by Region (2023-2028)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Acute Migraine Drugs Estimates and Projections (2017-2028)
2.4.2 Europe Acute Migraine Drugs Estimates and Projections (2017-2028)
2.4.3 China Acute Migraine Drugs Estimates and Projections (2017-2028)
2.4.4 Japan Acute Migraine Drugs Estimates and Projections (2017-2028)
2.4.5 Southeast Asia Acute Migraine Drugs Estimates and Projections (2017-2028)
2.4.6 India Acute Migraine Drugs Estimates and Projections (2017-2028)
3 Global Acute Migraine Drugs Competition Landscape by Players
3.1 Global Top Acute Migraine Drugs Players by Sales (2017-2022)
3.2 Global Top Acute Migraine Drugs Players by Revenue (2017-2022)
3.3 Global Acute Migraine Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Acute Migraine Drugs as of 2021)
3.4 Global Acute Migraine Drugs Average Price by Company (2017-2022)
3.5 Manufacturers Acute Migraine Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Acute Migraine Drugs Market Size by Type
4.1 Global Acute Migraine Drugs Historic Market Review by Type (2017-2022)
4.1.1 Global Acute Migraine Drugs Sales Market Share by Type (2017-2022)
4.1.2 Global Acute Migraine Drugs Revenue Market Share by Type (2017-2022)
4.1.3 Global Acute Migraine Drugs Price by Type (2017-2022)
4.2 Global Acute Migraine Drugs Market Estimates and Forecasts by Type (2023-2028)
4.2.1 Global Acute Migraine Drugs Sales Forecast by Type (2023-2028)
4.2.2 Global Acute Migraine Drugs Revenue Forecast by Type (2023-2028)
4.2.3 Global Acute Migraine Drugs Price Forecast by Type (2023-2028)
5 Global Acute Migraine Drugs Market Size by Application
5.1 Global Acute Migraine Drugs Historic Market Review by Application (2017-2022)
5.1.1 Global Acute Migraine Drugs Sales Market Share by Application (2017-2022)
5.1.2 Global Acute Migraine Drugs Revenue Market Share by Application (2017-2022)
5.1.3 Global Acute Migraine Drugs Price by Application (2017-2022)
5.2 Global Acute Migraine Drugs Market Estimates and Forecasts by Application (2023-2028)
5.2.1 Global Acute Migraine Drugs Sales Forecast by Application (2023-2028)
5.2.2 Global Acute Migraine Drugs Revenue Forecast by Application (2023-2028)
5.2.3 Global Acute Migraine Drugs Price Forecast by Application (2023-2028)
6 United States Acute Migraine Drugs Market Facts & Figures
6.1 United States Acute Migraine Drugs Sales by Company
6.1.1 United States Acute Migraine Drugs Sales by Company (2017-2022)
6.1.2 United States Acute Migraine Drugs Revenue by Company (2017-2022)
6.2 United States Acute Migraine Drugs Sales Breakdown by Type
6.2.1 United States Acute Migraine Drugs Sales Breakdown by Type (2017-2022)
6.2.2 United States Acute Migraine Drugs Sales Breakdown by Type (2023-2028)
6.3 United States Acute Migraine Drugs Sales Breakdown by Application
6.3.1 United States Acute Migraine Drugs Sales Breakdown by Application (2017-2022)
6.3.2 United States Acute Migraine Drugs Sales Breakdown by Application (2023-2028)
7 Europe Acute Migraine Drugs Market Facts & Figures
7.1 Europe Acute Migraine Drugs Sales by Company
7.1.1 Europe Acute Migraine Drugs Sales by Company (2017-2022)
7.1.2 Europe Acute Migraine Drugs Revenue by Company (2017-2022)
7.2 Europe Acute Migraine Drugs Sales Breakdown by Type
7.2.1 Europe Acute Migraine Drugs Sales Breakdown by Type (2017-2022)
7.2.2 Europe Acute Migraine Drugs Sales Breakdown by Type (2023-2028)
7.3 Europe Acute Migraine Drugs Sales Breakdown by Application
7.3.1 Europe Acute Migraine Drugs Sales Breakdown by Application (2017-2022)
7.3.2 Europe Acute Migraine Drugs Sales Breakdown by Application (2023-2028)
8 China Acute Migraine Drugs Market Facts & Figures
8.1 China Acute Migraine Drugs Sales by Company
8.1.1 China Acute Migraine Drugs Sales by Company (2017-2022)
8.1.2 China Acute Migraine Drugs Revenue by Company (2017-2022)
8.2 China Acute Migraine Drugs Sales Breakdown by Type
8.2.1 China Acute Migraine Drugs Sales Breakdown by Type (2017-2022)
8.2.2 China Acute Migraine Drugs Sales Breakdown by Type (2023-2028)
8.3 China Acute Migraine Drugs Sales Breakdown by Application
8.3.1 China Acute Migraine Drugs Sales Breakdown by Application (2017-2022)
8.3.2 China Acute Migraine Drugs Sales Breakdown by Application (2023-2028)
9 Japan Acute Migraine Drugs Market Facts & Figures
9.1 Japan Acute Migraine Drugs Sales by Company
9.1.1 Japan Acute Migraine Drugs Sales by Company (2017-2022)
9.1.2 Japan Acute Migraine Drugs Revenue by Company (2017-2022)
9.2 Japan Acute Migraine Drugs Sales Breakdown by Type
9.2.1 Japan Acute Migraine Drugs Sales Breakdown by Type (2017-2022)
9.2.2 Japan Acute Migraine Drugs Sales Breakdown by Type (2023-2028)
9.3 Japan Acute Migraine Drugs Sales Breakdown by Application
9.3.1 Japan Acute Migraine Drugs Sales Breakdown by Application (2017-2022)
9.3.2 Japan Acute Migraine Drugs Sales Breakdown by Application (2023-2028)
10 Southeast Asia Acute Migraine Drugs Market Facts & Figures
10.1 Southeast Asia Acute Migraine Drugs Sales by Company
10.1.1 Southeast Asia Acute Migraine Drugs Sales by Company (2017-2022)
10.1.2 Southeast Asia Acute Migraine Drugs Revenue by Company (2017-2022)
10.2 Southeast Asia Acute Migraine Drugs Sales Breakdown by Type
10.2.1 Southeast Asia Acute Migraine Drugs Sales Breakdown by Type (2017-2022)
10.2.2 Southeast Asia Acute Migraine Drugs Sales Breakdown by Type (2023-2028)
10.3 Southeast Asia Acute Migraine Drugs Sales Breakdown by Application
10.3.1 Southeast Asia Acute Migraine Drugs Sales Breakdown by Application (2017-2022)
10.3.2 Southeast Asia Acute Migraine Drugs Sales Breakdown by Application (2023-2028)
11 India Acute Migraine Drugs Market Facts & Figures
11.1 India Acute Migraine Drugs Sales by Company
11.1.1 India Acute Migraine Drugs Sales by Company (2017-2022)
11.1.2 India Acute Migraine Drugs Revenue by Company (2017-2022)
11.2 India Acute Migraine Drugs Sales Breakdown by Type
11.2.1 India Acute Migraine Drugs Sales Breakdown by Type (2017-2022)
11.2.2 India Acute Migraine Drugs Sales Breakdown by Type (2023-2028)
11.3 India Acute Migraine Drugs Sales Breakdown by Application
11.3.1 India Acute Migraine Drugs Sales Breakdown by Application (2017-2022)
11.3.2 India Acute Migraine Drugs Sales Breakdown by Application (2023-2028)
12 Company Profiles and Key Figures in Acute Migraine Drugs Business
12.1 GSK
12.1.1 GSK Corporation Information
12.1.2 GSK Business Overview
12.1.3 GSK Acute Migraine Drugs Sales, Revenue and Gross Margin (2017-2022)
12.1.4 GSK Acute Migraine Drugs Products Offered
12.1.5 GSK Recent Development
12.2 Teva
12.2.1 Teva Corporation Information
12.2.2 Teva Business Overview
12.2.3 Teva Acute Migraine Drugs Sales, Revenue and Gross Margin (2017-2022)
12.2.4 Teva Acute Migraine Drugs Products Offered
12.2.5 Teva Recent Development
12.3 Pfizer
12.3.1 Pfizer Corporation Information
12.3.2 Pfizer Business Overview
12.3.3 Pfizer Acute Migraine Drugs Sales, Revenue and Gross Margin (2017-2022)
12.3.4 Pfizer Acute Migraine Drugs Products Offered
12.3.5 Pfizer Recent Development
12.4 Novartis
12.4.1 Novartis Corporation Information
12.4.2 Novartis Business Overview
12.4.3 Novartis Acute Migraine Drugs Sales, Revenue and Gross Margin (2017-2022)
12.4.4 Novartis Acute Migraine Drugs Products Offered
12.4.5 Novartis Recent Development
12.5 Sun Pharma
12.5.1 Sun Pharma Corporation Information
12.5.2 Sun Pharma Business Overview
12.5.3 Sun Pharma Acute Migraine Drugs Sales, Revenue and Gross Margin (2017-2022)
12.5.4 Sun Pharma Acute Migraine Drugs Products Offered
12.5.5 Sun Pharma Recent Development
12.6 Grunenthal
12.6.1 Grunenthal Corporation Information
12.6.2 Grunenthal Business Overview
12.6.3 Grunenthal Acute Migraine Drugs Sales, Revenue and Gross Margin (2017-2022)
12.6.4 Grunenthal Acute Migraine Drugs Products Offered
12.6.5 Grunenthal Recent Development
12.7 Endo Pharmaceuticals
12.7.1 Endo Pharmaceuticals Corporation Information
12.7.2 Endo Pharmaceuticals Business Overview
12.7.3 Endo Pharmaceuticals Acute Migraine Drugs Sales, Revenue and Gross Margin (2017-2022)
12.7.4 Endo Pharmaceuticals Acute Migraine Drugs Products Offered
12.7.5 Endo Pharmaceuticals Recent Development
12.8 Merck
12.8.1 Merck Corporation Information
12.8.2 Merck Business Overview
12.8.3 Merck Acute Migraine Drugs Sales, Revenue and Gross Margin (2017-2022)
12.8.4 Merck Acute Migraine Drugs Products Offered
12.8.5 Merck Recent Development
12.9 J & J
12.9.1 J & J Corporation Information
12.9.2 J & J Business Overview
12.9.3 J & J Acute Migraine Drugs Sales, Revenue and Gross Margin (2017-2022)
12.9.4 J & J Acute Migraine Drugs Products Offered
12.9.5 J & J Recent Development
13 Acute Migraine Drugs Manufacturing Cost Analysis
13.1 Acute Migraine Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Acute Migraine Drugs
13.4 Acute Migraine Drugs Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Acute Migraine Drugs Distributors List
14.3 Acute Migraine Drugs Customers
15 Market Dynamics
15.1 Acute Migraine Drugs Industry Trends
15.2 Acute Migraine Drugs Market Drivers
15.3 Acute Migraine Drugs Market Challenges
15.4 Acute Migraine Drugs Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer